Claro Advisors’s BioTelemetry, Inc. BEAT Stock Holding History

Claro Advisors’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-2,987	Closed	-$193K	–	1121
2018 Q4	$193K	Buy	+2,987	New	+$179K	0.15%	138

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Claro Advisors's BEAT Position: Q1 2019 in Review

Claro Advisors sold out of BioTelemetry, Inc. (BEAT) in Q1 2019, closing a stake of 2,987 shares — an estimated $193K sold.

Claro Advisors first reported a position in BEAT in Q4 2018 and held it in 1 quarter. The position peaked at $193K in Q4 2018. 311 funds tracked by Wall St. Rank hold BEAT as of Q1 2019.

Claro Advisors reported no remaining BioTelemetry, Inc. position as of Q1 2019 after selling out during the quarter.
Claro Advisors sold 2,987 BioTelemetry, Inc. shares in Q1 2019, an estimated $193K.
Claro Advisors first reported a position in BioTelemetry, Inc. in Q4 2018 and held it in 1 quarter.
Claro Advisors's BioTelemetry, Inc. position peaked at $193K in Q4 2018.
311 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2019.

Based on Claro Advisors's 13F filing for Q1 2019, filed 10 May 2019.